Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
To provide information for the prompt identification and isolation of suspected MERS-CoV-infected patients and to prevent the spread of infection.
Goals and Outcomes
Goals and Learning Outcomes
Middle East respiratory syndrome (MERS) is a lethal pulmonary disease caused by a newly emerged coronavirus. The virus is transmitted to humans from dromedary (one-humped) camels and is not fully understood. It is believed to have originated in bats before it was transmitted to camels. Since human contact with bats is limited, evidence (serological and molecular) suggests that camels are the likely animal reservoir for MERS and the primary zoonotic source for human infection. MERS coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012. As of October 2018, there have been 2,266 lab confirmed cases of MERS with 804 deaths. The virus has been found in 27 countries.

After taking this course, you should be able to:

  • Explain MERS-CoV infections and how they are transmitted to humans.
  • Describe symptoms, complications, and diagnosis of patients with MERS-CoV infections.
  • Provide recommendations for preventing the transmission of MERS-CoV in hospitals.
  • Discuss how members of the interprofessional healthcare team can stem the spread of MERS-CoV in the acute care setting, both individually and collectively.
  • No
  • No
  • No
  • No

Course Termination Date: 12/31/23

Content Expiration Date: 09/30/22

Course Originally Released On: 05/01/19
Details
Course Details

Course Originally Released on : 5/1/2019

REL-ACU-0-CE747

Course Author

Barbara Barzoloski-O'Connor

MSN, RN, CIC

Catherine J. Swift

MT(ASCP)

Beth R. Wallace

MPH, CIC

Connie C. Chettle

MS, MPH, RN

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.